WATSON 3219 (Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg)
Pill imprint WATSON 3219 has been identified as Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg.
Aspirin/butalbital/caffeine is used in the treatment of migraine; pain; headache and belongs to the drug class analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine 325 mg / 50 mg / 40 mg has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
See also related documents.
- 325 mg / 50 mg / 40 mg
- Green & Yellow
- 29.00 mm
- Prescription only
D&C Yellow No. 10
FD&C Green No. 3
ferric oxide red
More about aspirin/butalbital/caffeine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.